Lyme disease vaccine candidate: Valneva and Pfizer report more positive Phase 2 data
by Press Release from Outbreak News Today on (#5VTQS)
NewsDesk @bactiman63 On Friday, Valneva and Pfizer reported further positive Phase 2 data for their Lyme disease vaccine candidate, VLA15. Based on these new results, Valneva and Pfizer plan to proceed with a three-dose primary series vaccination schedule in a planned Phase 3 clinical trial. The trial will evaluate VLA15 in adults and pediatric subjects 5 [...]
The post Lyme disease vaccine candidate: Valneva and Pfizer report more positive Phase 2 data appeared first on Outbreak News Today.